TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs62573974
log Bayes Factor = 21.5749
Chromosome 9   position 100,536,542  (GRCh37) Explore rs62573974 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
1.000 0.000 0.000
E04.2 Non-toxic multinodular goitre
1.000 0.000 0.000
E04 Other non-toxic goitre
1.000 0.000 0.000
E03 Other hypothyroidism
1.000 0.000 0.000
E00-E07 Disorders of thyroid gland
1.000 0.000 0.000
E04.9 Non-toxic goitre, unspecified
0.984 0.016 0.000
E06 Thyroiditis
0.911 0.089 0.000
E04.0 Non-toxic diffuse goitre
0.873 0.127 0.000
E06.3 Autoimmune thyroiditis
0.830 0.170 0.000
E07 Other disorders of thyroid
0.820 0.180 0.000
E03.1 Congenital hypothyroidism without goitre
0.801 0.199 0.000
E03.0 Congenital hypothyroidism with diffuse goitre
0.767 0.233 0.000
E06.9 Thyroiditis, unspecified
0.755 0.245 0.000
E03.8 Other specified hypothyroidism
0.728 0.272 0.000
E04.8 Other specified non-toxic goitre
0.717 0.283 0.000
E03.5 Myxoedema coma
0.717 0.283 0.000
E03.4 Atrophy of thyroid (acquired)
0.717 0.283 0.000
E03.3 Postinfectious hypothyroidism
0.717 0.283 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.717 0.283 0.000
E00 Congenital iodine-deficiency syndrome
0.717 0.283 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.701 0.299 0.000
E07.9 Disorder of thyroid, unspecified
0.694 0.306 0.000
E06.4 Drug-induced thyroiditis
0.653 0.347 0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.653 0.347 0.000
E06.1 Subacute thyroiditis
0.653 0.347 0.000
E06.0 Acute thyroiditis
0.653 0.347 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.646 0.354 0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.609 0.390 0.000
E07.1 Dyshormogenetic goitre
0.588 0.412 0.000
E07.0 Hypersecretion of calcitonin
0.588 0.412 0.000
E07.8 Other specified disorders of thyroid
0.584 0.416 0.000
E06.5 Other chronic thyroiditis
0.573 0.427 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.564 0.436 0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.514 0.486 0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.514 0.486 0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.514 0.486 0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.514 0.486 0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.514 0.486 0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.514 0.486 0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.514 0.486 0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.514 0.486 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.486 0.513 0.000
E05.5 Thyroid crisis or storm
0.463 0.537 0.000
E05.4 Thyrotoxicosis factitia
0.463 0.537 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.463 0.537 0.000
E05.8 Other thyrotoxicosis
0.458 0.541 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.330 0.670 0.000
E05.9 Thyrotoxicosis, unspecified
0.281 0.719 0.000
C73 Malignant neoplasm of thyroid gland
0.000 0.733 0.267
E23 Hypofunction and other disorders of pituitary gland
0.240 0.760 0.000
E20-E35 Disorders of other endocrine glands
0.239 0.761 0.000
E23.2 Diabetes insipidus
0.237 0.763 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.231 0.769 0.000
E27 Other disorders of adrenal gland
0.221 0.779 0.000
E23.0 Hypopituitarism
0.220 0.780 0.000
E29 Testicular dysfunction
0.215 0.785 0.000
E04.1 Non-toxic single thyroid nodule
0.210 0.790 0.000
E34 Other endocrine disorders
0.205 0.795 0.000
E27.9 Disorder of adrenal gland, unspecified
0.203 0.797 0.000
E29.1 Testicular hypofunction
0.198 0.802 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.192 0.808 0.000
E28 Ovarian dysfunction
0.191 0.809 0.000
E34.9 Endocrine disorder, unspecified
0.187 0.813 0.000
E23.7 Disorder of pituitary gland, unspecified
0.181 0.819 0.000
E27.1 Primary adrenocortical insufficiency
0.180 0.820 0.000
E24 Cushing's syndrome
0.176 0.824 0.000
E25 Adrenogenital disorders
0.174 0.826 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.172 0.828 0.000
E23.1 Drug-induced hypopituitarism
0.172 0.828 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.172 0.828 0.000
E32 Diseases of thymus
0.172 0.828 0.000
E30 Disorders of puberty, not elsewhere classified
0.172 0.828 0.000
E31 Polyglandular dysfunction
0.170 0.830 0.000
E27.5 Adrenomedullary hyperfunction
0.159 0.841 0.000
E27.0 Other adrenocortical overactivity
0.159 0.841 0.000
E27.3 Drug-induced adrenocortical insufficiency
0.157 0.843 0.000
E34.3 Short stature, not elsewhere classified
0.156 0.844 0.000
E29.9 Testicular dysfunction, unspecified
0.155 0.845 0.000
E29.8 Other testicular dysfunction
0.155 0.845 0.000
E29.0 Testicular hyperfunction
0.155 0.845 0.000
E28.3 Primary ovarian failure
0.154 0.846 0.000
E22 Hyperfunction of pituitary gland
0.153 0.847 0.000
E34.5 Androgen resistance syndrome
0.147 0.853 0.000
E34.4 Constitutional tall stature
0.147 0.853 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.147 0.853 0.000
E34.1 Other hypersecretion of intestinal hormones
0.147 0.853 0.000
E23.6 Other disorders of pituitary gland
0.141 0.859 0.000
E28.2 Polycystic ovarian syndrome
0.141 0.859 0.000
E26 Hyperaldosteronism
0.140 0.860 0.000
E20 Hypoparathyroidism
0.140 0.860 0.000
E28.9 Ovarian dysfunction, unspecified
0.137 0.863 0.000
E28.8 Other ovarian dysfunction
0.137 0.863 0.000
E28.1 Androgen excess
0.137 0.863 0.000
E28.0 Oestrogen excess
0.137 0.863 0.000
E27.2 Addisonian crisis
0.135 0.864 0.000
E34.0 Carcinoid syndrome
0.134 0.866 0.000
E34.8 Other specified endocrine disorders
0.131 0.868 0.000
E24.2 Drug-induced Cushing's syndrome
0.130 0.870 0.000
E24.8 Other Cushing's syndrome
0.129 0.871 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.127 0.872 0.000
E24.9 Cushing's syndrome, unspecified
0.126 0.874 0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.126 0.874 0.000
E24.3 Ectopic ACTH syndrome
0.126 0.874 0.000
E24.1 Nelson's syndrome
0.126 0.874 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.126 0.874 0.000
E25.9 Adrenogenital disorder, unspecified
0.125 0.875 0.000
E25.8 Other adrenogenital disorders
0.125 0.875 0.000
E24.0 Pituitary-dependent Cushing's disease
0.124 0.876 0.000
E30.9 Disorder of puberty, unspecified
0.123 0.877 0.000
E30.8 Other disorders of puberty
0.123 0.877 0.000
E30.1 Precocious puberty
0.123 0.877 0.000
E30.0 Delayed puberty
0.123 0.877 0.000
E32.9 Disease of thymus, unspecified
0.123 0.877 0.000
E32.8 Other diseases of thymus
0.123 0.877 0.000
E32.1 Abscess of thymus
0.123 0.877 0.000
E32.0 Persistent hyperplasia of thymus
0.123 0.877 0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.123 0.877 0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.123 0.877 0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.123 0.877 0.000
E31.9 Polyglandular dysfunction, unspecified
0.122 0.878 0.000
E31.8 Other polyglandular dysfunction
0.122 0.878 0.000
E31.1 Polyglandular hyperfunction
0.122 0.878 0.000
E31.0 Autoimmune polyglandular failure
0.120 0.880 0.000
E40-E46 Malnutrition
0.120 0.880 0.000
E22.0 Acromegaly and pituitary gigantism
0.119 0.881 0.000
E27.8 Other specified disorders of adrenal gland
0.118 0.882 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.110 0.889 0.000
E22.8 Other hyperfunction of pituitary gland
0.110 0.890 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.108 0.892 0.000
E65-E68 Obesity and other hyperalimentation
0.103 0.897 0.000
E26.8 Other hyperaldosteronism
0.100 0.899 0.000
E26.1 Secondary hyperaldosteronism
0.100 0.899 0.000
E20.8 Other hypoparathyroidism
0.100 0.899 0.000
E20.1 Pseudohypoparathyroidism
0.100 0.899 0.000
E20.0 Idiopathic hypoparathyroidism
0.100 0.899 0.000
E26.9 Hyperaldosteronism, unspecified
0.096 0.904 0.000
E15 Nondiabetic hypoglycaemic coma
0.090 0.909 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.086 0.914 0.000
E45 Retarded development following protein-energy malnutrition
0.086 0.914 0.000
E43 Unspecified severe protein-energy malnutrition
0.086 0.914 0.000
E42 Marasmic kwashiorkor
0.086 0.914 0.000
E41 Nutritional marasmus
0.086 0.914 0.000
E40 Kwashiorkor
0.086 0.914 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.000 0.916 0.084
E26.0 Primary hyperaldosteronism
0.075 0.924 0.000
E22.1 Hyperprolactinaemia
0.075 0.925 0.000
E67 Other hyperalimentation
0.074 0.926 0.000
E68 Sequelae of hyperalimentation
0.074 0.926 0.000
E20.9 Hypoparathyroidism, unspecified
0.068 0.931 0.000
E65 Localised adiposity
0.064 0.936 0.000
E44.1 Mild protein-energy malnutrition
0.062 0.938 0.000
E44.0 Moderate protein-energy malnutrition
0.062 0.938 0.000
C75 Malignant neoplasm of other endocrine glands and related structures
0.000 0.944 0.055
C74 Malignant neoplasm of adrenal gland
0.000 0.946 0.054
E67.8 Other specified hyperalimentation
0.053 0.946 0.000
E67.3 Hypervitaminosis D
0.053 0.946 0.000
E67.2 Megavitamin-B6 syndrome
0.053 0.946 0.000
E67.1 Hypercarotenaemia
0.053 0.946 0.000
E67.0 Hypervitaminosis A
0.053 0.946 0.000
E50-E64 Other nutritional deficiencies
0.051 0.949 0.000
E16 Other disorders of pancreatic internal secretion
0.050 0.950 0.000
C67 Malignant neoplasm of bladder
0.000 0.951 0.049
C67.4 Posterior wall of bladder
0.000 0.953 0.047
C67.2 Lateral wall of bladder
0.000 0.953 0.047
E70-E90 Metabolic disorders
0.043 0.957 0.000
C67.0 Trigone of bladder
0.000 0.957 0.043
C67.5 Bladder neck
0.000 0.957 0.043
R07.2 Precordial pain
0.000 0.957 0.043
E85 Amyloidosis
0.042 0.958 0.000
C74.9 Adrenal gland, unspecified
0.000 0.959 0.041
C67.9 Bladder, unspecified
0.000 0.959 0.041
C67.1 Dome of bladder
0.000 0.960 0.040
C75.8 Pluriglandular involvement, unspecified
0.000 0.960 0.040
C75.5 Aortic body and other paraganglia
0.000 0.960 0.040
C75.4 Carotid body
0.000 0.960 0.040
C75.3 Pineal gland
0.000 0.960 0.040
C75.2 Craniopharyngeal duct
0.000 0.960 0.040
C75.0 Parathyroid gland
0.000 0.960 0.040
E46 Unspecified protein-energy malnutrition
0.040 0.960 0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.039 0.961 0.000
C75.1 Pituitary gland
0.000 0.961 0.039
C67.8 Overlapping lesion of bladder
0.000 0.961 0.039
E89.0 Postprocedural hypothyroidism
0.038 0.962 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.037 0.963 0.000
E63 Other nutritional deficiencies
0.037 0.963 0.000
E50 Vitamin A deficiency
0.037 0.963 0.000
E60 Dietary zinc deficiency
0.037 0.963 0.000
E59 Dietary selenium deficiency
0.037 0.963 0.000
E54 Ascorbic acid deficiency
0.037 0.963 0.000
E52 Niacin deficiency [pellagra]
0.037 0.963 0.000
E85.9 Amyloidosis, unspecified
0.037 0.963 0.000
E79 Disorders of purine and pyrimidine metabolism
0.037 0.963 0.000
C74.1 Medulla of adrenal gland
0.000 0.964 0.036
E16.9 Disorder of pancreatic internal secretion, unspecified
0.036 0.964 0.000
E16.8 Other specified disorders of pancreatic internal secretion
0.036 0.964 0.000
E16.4 Abnormal secretion of gastrin
0.036 0.964 0.000
E16.3 Increased secretion of glucagon
0.036 0.964 0.000
E58 Dietary calcium deficiency
0.036 0.964 0.000
C75.9 Endocrine gland, unspecified
0.000 0.964 0.036
E16.1 Other hypoglycaemia
0.036 0.964 0.000
E74 Other disorders of carbohydrate metabolism
0.036 0.964 0.000
C67.7 Urachus
0.000 0.965 0.035
E66 Obesity
0.035 0.965 0.000
E85.8 Other amyloidosis
0.035 0.965 0.000
E88 Other metabolic disorders
0.035 0.965 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.034 0.966 0.000
C74.0 Cortex of adrenal gland
0.000 0.966 0.033
E56 Other vitamin deficiencies
0.033 0.967 0.000
E51 Thiamine deficiency
0.032 0.967 0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.032 0.968 0.000
E85.4 Organ-limited amyloidosis
0.032 0.968 0.000
E85.3 Secondary systemic amyloidosis
0.032 0.968 0.000
E70 Disorders of aromatic amino-acid metabolism
0.032 0.968 0.000
E84 Cystic fibrosis
0.032 0.968 0.000
E72 Other disorders of amino-acid metabolism
0.032 0.968 0.000
E77 Disorders of glycoprotein metabolism
0.031 0.969 0.000
E76 Disorders of glycosaminoglycan metabolism
0.031 0.969 0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.031 0.969 0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.031 0.969 0.000
E89.4 Postprocedural ovarian failure
0.031 0.969 0.000
C67.6 Ureteric orifice
0.000 0.970 0.030
E85.2 Heredofamilial amyloidosis, unspecified
0.030 0.970 0.000
E85.1 Neuropathic heredofamilial amyloidosis
0.030 0.970 0.000
E85.0 Nonneuropathic heredofamilial amyloidosis
0.030 0.970 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.029 0.970 0.000
C67.3 Anterior wall of bladder
0.000 0.970 0.030
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.029 0.971 0.000
Z48.8 Other specified surgical follow-up care
0.029 0.971 0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.028 0.972 0.000
E89.5 Postprocedural testicular hypofunction
0.028 0.972 0.000
E89.1 Postprocedural hypoinsulinaemia
0.028 0.972 0.000
E89.2 Postprocedural hypoparathyroidism
0.028 0.972 0.000
E88.2 Lipomatosis, not elsewhere classified
0.028 0.972 0.000
E74.3 Other disorders of intestinal carbohydrate absorption
0.028 0.972 0.000
E74.0 Glycogen storage disease
0.028 0.972 0.000
E53 Deficiency of other B group vitamins
0.028 0.972 0.000
E55 Vitamin D deficiency
0.028 0.972 0.000
E89.8 Other postprocedural endocrine and metabolic disorders
0.027 0.972 0.000
E88.9 Metabolic disorder, unspecified
0.027 0.973 0.000
E50.9 Vitamin A deficiency, unspecified
0.027 0.973 0.000
E50.8 Other manifestations of vitamin A deficiency
0.027 0.973 0.000
E50.7 Other ocular manifestations of vitamin A deficiency
0.027 0.973 0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.027 0.973 0.000
E50.5 Vitamin A deficiency with night blindness
0.027 0.973 0.000
E50.4 Vitamin A deficiency with keratomalacia
0.027 0.973 0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.027 0.973 0.000
E50.2 Vitamin A deficiency with corneal xerosis
0.027 0.973 0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.027 0.973 0.000
E50.0 Vitamin A deficiency with conjunctival xerosis
0.027 0.973 0.000
E63.9 Nutritional deficiency, unspecified
0.027 0.973 0.000
E63.8 Other specified nutritional deficiencies
0.027 0.973 0.000
E63.1 Imbalance of constituents of food intake
0.027 0.973 0.000
E63.0 Essential fatty acid [EFA] deficiency
0.027 0.973 0.000
E64.9 Sequelae of unspecified nutritional deficiency
0.027 0.973 0.000
E64.8 Sequelae of other nutritional deficiencies
0.027 0.973 0.000
E64.3 Sequelae of rickets
0.027 0.973 0.000
E64.2 Sequelae of vitamin C deficiency
0.027 0.973 0.000
E64.1 Sequelae of vitamin A deficiency
0.027 0.973 0.000
E64.0 Sequelae of protein-energy malnutrition
0.027 0.973 0.000
E88.3 Tumour lysis syndrome
0.027 0.973 0.000
E88.1 Lipodystrophy, not elsewhere classified
0.027 0.973 0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.027 0.973 0.000
E79.8 Other disorders of purine and pyrimidine metabolism
0.027 0.973 0.000
E79.1 Lesch-Nyhan syndrome
0.027 0.973 0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.027 0.973 0.000
E74.9 Disorder of carbohydrate metabolism, unspecified
0.026 0.974 0.000
E74.8 Other specified disorders of carbohydrate metabolism
0.026 0.974 0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.026 0.974 0.000
E74.2 Disorders of galactose metabolism
0.026 0.974 0.000
E74.1 Disorders of fructose metabolism
0.026 0.974 0.000
E66.1 Drug-induced obesity
0.025 0.975 0.000
E73 Lactose intolerance
0.025 0.975 0.000
E66.0 Obesity due to excess calories
0.025 0.975 0.000
E66.2 Extreme obesity with alveolar hypoventilation
0.025 0.975 0.000
E88.8 Other specified metabolic disorders
0.024 0.976 0.000
E56.9 Vitamin deficiency, unspecified
0.024 0.976 0.000
E56.8 Deficiency of other vitamins
0.024 0.976 0.000
E56.0 Deficiency of vitamin E
0.024 0.976 0.000
E70.3 Albinism
0.024 0.976 0.000
E61 Deficiency of other nutrient elements
0.024 0.976 0.000
E51.9 Thiamine deficiency, unspecified
0.023 0.976 0.000
E51.8 Other manifestations of thiamine deficiency
0.023 0.976 0.000
E51.1 Beriberi
0.023 0.976 0.000
E84.9 Cystic fibrosis, unspecified
0.024 0.976 0.000
E72.0 Disorders of amino-acid transport
0.023 0.977 0.000
E89.3 Postprocedural hypopituitarism
0.023 0.977 0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.023 0.977 0.000
E70.8 Other disorders of aromatic amino-acid metabolism
0.023 0.977 0.000
E70.2 Disorders of tyrosine metabolism
0.023 0.977 0.000
E70.1 Other hyperphenylalaninaemias
0.023 0.977 0.000
E70.0 Classical phenylketonuria
0.023 0.977 0.000
E84.8 Cystic fibrosis with other manifestations
0.023 0.977 0.000
E84.1 Cystic fibrosis with intestinal manifestations
0.023 0.977 0.000
E84.0 Cystic fibrosis with pulmonary manifestations
0.023 0.977 0.000
E72.9 Disorder of amino-acid metabolism, unspecified
0.023 0.977 0.000
E72.8 Other specified disorders of amino-acid metabolism
0.023 0.977 0.000
E72.5 Disorders of glycine metabolism
0.023 0.977 0.000
E72.4 Disorders of ornithine metabolism
0.023 0.977 0.000
E72.3 Disorders of lysine and hydroxylysine metabolism
0.023 0.977 0.000
E72.2 Disorders of urea cycle metabolism
0.023 0.977 0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.023 0.977 0.000
E71.3 Disorders of fatty-acid metabolism
0.023 0.977 0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.023 0.977 0.000
E71.1 Other disorders of branched-chain amino-acid metabolism
0.023 0.977 0.000
E71.0 Maple-syrup-urine disease
0.023 0.977 0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.023 0.977 0.000
E76.8 Other disorders of glucosaminoglycan metabolism
0.023 0.977 0.000
E76.3 Mucopolysaccharidosis, unspecified
0.023 0.977 0.000
E76.2 Other mucopolysaccharidoses
0.023 0.977 0.000
E76.1 Mucopolysaccharidosis, type II
0.023 0.977 0.000
E76.0 Mucopolysaccharidosis, type I
0.023 0.977 0.000
E77.9 Disorder of glycoprotein metabolism, unspecified
0.023 0.977 0.000
E77.8 Other disorders of glycoprotein metabolism
0.023 0.977 0.000
E77.1 Defects in glycoprotein degradation
0.023 0.977 0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.023 0.977 0.000
E66.8 Other obesity
0.023 0.977 0.000
E53.9 Vitamin B deficiency, unspecified
0.022 0.978 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.021 0.979 0.000
E75.6 Lipid storage disorder, unspecified
0.021 0.979 0.000
E75.4 Neuronal ceroid lipofuscinosis
0.021 0.979 0.000
E75.3 Sphingolipidosis, unspecified
0.021 0.979 0.000
E75.2 Other sphingolipidosis
0.021 0.979 0.000
E75.1 Other gangliosidosis
0.021 0.979 0.000
E75.0 GM2 gangliosidosis
0.021 0.979 0.000
E21.2 Other hyperparathyroidism
0.020 0.979 0.000
E21.4 Other specified disorders of parathyroid gland
0.020 0.980 0.000
E56.1 Deficiency of vitamin K
0.020 0.980 0.000
E53.1 Pyridoxine deficiency
0.020 0.980 0.000
E53.0 Riboflavin deficiency
0.020 0.980 0.000
E55.0 Rickets, active
0.020 0.980 0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.020 0.980 0.000
E51.2 Wernicke's encephalopathy
0.019 0.981 0.000
C64-C68 Malignant neoplasms of urinary tract
0.000 0.981 0.019
E75.5 Other lipid storage disorders
0.019 0.981 0.000
E73.8 Other lactose intolerance
0.018 0.981 0.000
E73.1 Secondary lactase deficiency
0.018 0.981 0.000
E73.0 Congenital lactase deficiency
0.018 0.981 0.000
E61.9 Deficiency of nutrient element, unspecified
0.017 0.983 0.000
E61.8 Deficiency of other specified nutrient elements
0.017 0.983 0.000
E61.7 Deficiency of multiple nutrient elements
0.017 0.983 0.000
E61.6 Vanadium deficiency
0.017 0.983 0.000
E61.5 Molybdenum deficiency
0.017 0.983 0.000
E61.4 Chromium deficiency
0.017 0.983 0.000
E61.3 Manganese deficiency
0.017 0.983 0.000
E61.0 Copper deficiency
0.017 0.983 0.000
C65 Malignant neoplasm of renal pelvis
0.000 0.983 0.017
C68 Malignant neoplasm of other and unspecified urinary organs
0.000 0.985 0.015
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.013 0.986 0.001
E80 Disorders of porphyrin and bilirubin metabolism
0.013 0.987 0.000
E61.2 Magnesium deficiency
0.013 0.987 0.000
X62.9 Unspecified place
0.000 0.987 0.013
C66 Malignant neoplasm of ureter
0.000 0.987 0.013
E73.9 Lactose intolerance, unspecified
0.012 0.987 0.000
C68.9 Urinary organ, unspecified
0.000 0.988 0.012
E61.1 Iron deficiency
0.011 0.988 0.000
E10-E14 Diabetes mellitus
0.012 0.988 0.000
C68.0 Urethra
0.000 0.989 0.011
C68.8 Overlapping lesion of urinary organs
0.000 0.989 0.011
C68.1 Paraurethral glands
0.000 0.989 0.011
E55.9 Vitamin D deficiency, unspecified
0.011 0.989 0.000
D39.1 Ovary
0.010 0.990 0.000
E21.0 Primary hyperparathyroidism
0.010 0.990 0.000
E80.7 Disorder of bilirubin metabolism, unspecified
0.009 0.990 0.000
E80.5 Crigler-Najjar syndrome
0.009 0.990 0.000
E80.3 Defects of catalase and peroxydase
0.009 0.990 0.000
E80.0 Hereditary erythropoietic porphyria
0.009 0.990 0.000
E80.1 Porphyria cutanea tarda
0.009 0.991 0.000
Z02.8 Other examinations for administrative purposes
0.000 0.991 0.009
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)
0.009 0.991 0.000
E12 Malnutrition-related diabetes mellitus
0.008 0.991 0.000
E80.2 Other porphyria
0.008 0.992 0.000
D25.0 Submucous leiomyoma of uterus
0.008 0.992 0.000
E80.6 Other disorders of bilirubin metabolism
0.008 0.992 0.000
Z63.4 Disappearance and death of family member
0.000 0.992 0.008
C64 Malignant neoplasm of kidney, except renal pelvis
0.000 0.993 0.007
E53.8 Deficiency of other specified B group vitamins
0.006 0.994 0.000
E12.9 Without complications
0.006 0.994 0.000
E12.8 With unspecified complications
0.006 0.994 0.000
E12.7 With multiple complications
0.006 0.994 0.000
E12.6 With other specified complications
0.006 0.994 0.000
E12.5 With peripheral circulatory complications
0.006 0.994 0.000
E12.4 With neurological complications
0.006 0.994 0.000
E12.3 With ophthalmic complications
0.006 0.994 0.000
E12.2 With renal complications
0.006 0.994 0.000
E12.1 With ketoacidosis
0.006 0.994 0.000
E12.0 With coma
0.006 0.994 0.000
Z63 Other problems related to primary support group, including family circumstances
0.000 0.994 0.006
Z51.0 Radiotherapy session
0.000 0.994 0.006
K57.1 Diverticular disease of small intestine without perforation or abscess
0.006 0.994 0.000
Z63.5 Disruption of family by separation and divorce
0.000 0.994 0.006
E13 Other specified diabetes mellitus
0.006 0.994 0.000
Z63.7 Other stressful life events affecting family and household
0.000 0.994 0.006
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.000 0.994 0.006
J31.0 Chronic rhinitis
0.000 0.995 0.005
G93.8 Other specified disorders of brain
0.000 0.995 0.005
S39.9 Unspecified injury of abdomen, lower back and pelvis
0.000 0.995 0.005
Z63.0 Problems in relationship with spouse or partner
0.000 0.995 0.005
E16.2 Hypoglycaemia, unspecified
0.005 0.995 0.000
O47.1 False labour at or after 37 completed weeks of gestation
0.000 0.995 0.005
Z63.6 Dependent relative needing care at home
0.000 0.995 0.005
Z63.9 Problem related to primary support group, unspecified
0.000 0.995 0.005
Z63.3 Absence of family member
0.000 0.995 0.005
Z63.2 Inadequate family support
0.000 0.995 0.005
Z63.1 Problems in relationship with parents and in-laws
0.000 0.995 0.005
E21.3 Hyperparathyroidism, unspecified
0.004 0.995 0.001
E14 Unspecified diabetes mellitus
0.005 0.995 0.000
O47.0 False labour before 37 completed weeks of gestation
0.000 0.995 0.005
K08.3 Retained dental root
0.000 0.995 0.005
G83.2 Monoplegia of upper limb
0.000 0.995 0.004
E13.8 With unspecified complications
0.004 0.996 0.000
E13.7 With multiple complications
0.004 0.996 0.000
E13.6 With other specified complications
0.004 0.996 0.000
E13.5 With peripheral circulatory complications
0.004 0.996 0.000
E13.4 With neurological complications
0.004 0.996 0.000
E13.2 With renal complications
0.004 0.996 0.000
E13.1 With ketoacidosis
0.004 0.996 0.000
E13.0 With coma
0.004 0.996 0.000
X62.0 Home
0.000 0.996 0.004
X62.7 Farm
0.000 0.996 0.004
X62.6 Industrial and construction area
0.000 0.996 0.004
X62.5 Trade and service area
0.000 0.996 0.004
X62.4 Street and highway
0.000 0.996 0.004
X62.3 Sports and athletics area
0.000 0.996 0.004
X62.2 School, other institution and public administrative area
0.000 0.996 0.004
X62.1 Residential institution
0.000 0.996 0.004
E13.3 With ophthalmic complications
0.004 0.996 0.000
G83.4 Cauda equina syndrome
0.000 0.996 0.004
G83.8 Other specified paralytic syndromes
0.000 0.996 0.004
M21.57 Acquired clawhand, clubhand, clawfoot and clubfoot (Ankle and foot)
0.000 0.996 0.004
G83 Other paralytic syndromes
0.000 0.996 0.004
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.004 0.996 0.000
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)
0.004 0.996 0.000
E14.2 Withrenal complications
0.004 0.996 0.000
I78.1 Naevus, nonneoplastic
0.000 0.996 0.004
C79.9 Secondary malignant neoplasm, unspecified site
0.000 0.996 0.004
E14.4 With neurological complications
0.004 0.996 0.000
D37.4 Colon
0.000 0.996 0.004
N11.9 Chronic tubulo-interstitial nephritis, unspecified
0.000 0.996 0.004
Z02 Examination and encounter for administrative purposes
0.000 0.996 0.004
R70.0 Elevated erythrocyte sedimentation rate
0.004 0.996 0.000
S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)
0.004 0.996 0.000
X62.8 Other specified place
0.000 0.996 0.003
E14.1 With ketoacidosis
0.004 0.996 0.000
E14.7 With multiple complications
0.003 0.996 0.000
E14.0 With coma
0.003 0.996 0.000
E14.6 With other specified complications
0.003 0.996 0.000
T90.5 Sequelae of intracranial injury
0.000 0.996 0.004
O47 False labour
0.000 0.996 0.004
E14.8 With unspecified complications
0.003 0.996 0.000
F43.2 Adjustment disorders
0.003 0.997 0.000
T40.2 Other opioids
0.000 0.997 0.003
M94.86 Other specified disorders of cartilage (Lower leg)
0.000 0.997 0.003
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.997 0.003
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity
0.000 0.997 0.003
D25.2 Subserosal leiomyoma of uterus
0.003 0.997 0.000
G83.9 Paralytic syndrome, unspecified
0.000 0.997 0.003
E14.5 With peripheral circulatory complications
0.003 0.997 0.000
G83.5 Locked-in syndrome
0.000 0.997 0.003
G83.3 Monoplegia, unspecified
0.000 0.997 0.003
G83.0 Diplegia of upper limbs
0.000 0.997 0.003
Z63.8 Other specified problems related to primary support group
0.000 0.997 0.003
C50.8 Overlapping lesion of breast
0.003 0.997 0.000
D39.9 Female genital organ, unspecified
0.003 0.997 0.000
D39.2 Placenta
0.003 0.997 0.000
E83 Disorders of mineral metabolism
0.003 0.997 0.000
Z48 Other surgical follow-up care
0.003 0.997 0.000
D39.0 Uterus
0.003 0.997 0.000
M65.9 Synovitis and tenosynovitis, unspecified
0.003 0.997 0.000
N73.6 Female pelvic peritoneal adhesions
0.003 0.997 0.000
D39.7 Other female genital organs
0.003 0.997 0.000
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)
0.003 0.997 0.000
D25 Leiomyoma of uterus
0.003 0.997 0.000
E80.4 Gilbert's syndrome
0.003 0.997 0.000
Z02.9 Examination for administrative purposes, unspecified
0.000 0.997 0.003
Z02.7 Issue of medical certificate
0.000 0.997 0.003
Z02.6 Examination for insurance purposes
0.000 0.997 0.003
Z02.5 Examination for participation in sport
0.000 0.997 0.003
Z02.4 Examination for driving licence
0.000 0.997 0.003
Z02.3 Examination for recruitment to armed forces
0.000 0.997 0.003
Z02.2 Examination for admission to residential institution
0.000 0.997 0.003
Z02.1 Pre-employment examination
0.000 0.997 0.003
Z02.0 Examination for admission to educational institution
0.000 0.997 0.003
M07.30 Other psoriatic arthropathies (Multiple sites)
0.003 0.997 0.000
L81.9 Disorder of pigmentation, unspecified
0.003 0.997 0.000
M07.36 Other psoriatic arthropathies (Lower leg)
0.003 0.997 0.000
K08.1 Loss of teeth due to accident, extraction or local periodontal disease
0.000 0.997 0.003
T90.8 Sequelae of other specified injuries of head
0.000 0.997 0.003
K08.2 Atrophy of edentulous alveolar ridge
0.000 0.997 0.003
K08 Other disorders of teeth and supporting structures
0.000 0.997 0.003
T90 Sequelae of injuries of head
0.000 0.997 0.003
E83.8 Other disorders of mineral metabolism
0.002 0.997 0.000
E83.2 Disorders of zinc metabolism
0.002 0.997 0.000
E83.0 Disorders of copper metabolism
0.002 0.997 0.000
G83.1 Monoplegia of lower limb
0.000 0.997 0.002
M65.98 Synovitis and tenosynovitis, unspecified (Other)
0.002 0.997 0.000
T90.0 Sequelae of superficial injury of head
0.000 0.997 0.003
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)
0.002 0.997 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.002 0.997 0.000
T90.9 Sequelae of unspecified injury of head
0.000 0.997 0.002
S39 Other and unspecified injuries of abdomen, lower back and pelvis
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.